We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$275B
AUM Growth
+$31.9B
Cap. Flow
+$25.4B
Cap. Flow %
9.21%
Top 10 Hldgs %
24.05%
Holding
11,369
New
2,651
Increased
3,766
Reduced
3,644
Closed
1,221

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$429M
2
BA icon
Boeing
BA
+$402M
3
COTY icon
Coty
COTY
+$284M
4
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$104M
5
QCOM icon
Qualcomm
QCOM
+$102M

Sector Composition

Rank Sector Weight
1 Technology 2.44%
2 Consumer Discretionary 1.83%
3 Communication Services 1.72%
4 Financials 1.35%
5 Healthcare 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
1051
PUT
HCA Healthcare
HCA
$92.9B
$27.9M 0.01%
206,500
+30,100
+17% +$3.81M
GGAL icon
1052
CALL
Galicia Financial Group
GGAL
$6.98B
$27.8M 0.01%
783,400
+242,400
+45% +$6.5M
AEM icon
1053
PUT
Agnico Eagle Mines
AEM
$110B
$27.8M 0.01%
542,300
+90,800
+20% +$3.96M
SDS icon
1054
PUT
ProShares UltraShort S&P500
SDS
$399M
$27.8M 0.01%
36,176
+14,416
+66% +$11.6M
QLD icon
1055
PUT
ProShares Ultra QQQ
QLD
$13.6B
$27.8M 0.01%
2,313,600
+600,800
+35% +$7.03M
ICPT
1056
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$27.8M 0.01%
348,900
-367,300
-51% -$32.9M
TNDM icon
1057
CALL
Tandem Diabetes Care
TNDM
$1.55B
$27.7M 0.01%
428,800
-98,000
-19% -$6.32M
IHI icon
1058
PUT
iShares US Medical Devices ETF
IHI
$3.45B
$27.6M 0.01%
688,200
+619,800
+906% +$23.5M
NWL icon
1059
PUT
Newell Brands
NWL
$2.59B
$27.6M 0.01%
1,787,900
-813,400
-31% -$12.2M
CIEN icon
1060
CALL
Ciena
CIEN
$52.7B
$27.5M 0.01%
669,000
+28,400
+4% +$1.09M
VTRS icon
1061
CALL
Viatris
VTRS
$19B
$27.4M 0.01%
1,438,600
+146,000
+11% +$3.23M
SCO icon
1062
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$722M
$27.4M 0.01%
19,993
-533
-3% -$717K
RGLD icon
1063
CALL
Royal Gold
RGLD
$22.3B
$27.4M 0.01%
267,100
-57,100
-18% -$5.14M
QRVO icon
1064
PUT
Qorvo
QRVO
$8.41B
$27.3M 0.01%
410,500
+274,000
+201% +$19M
BHP icon
1065
PUT
BHP
BHP
$247B
$27.3M 0.01%
526,758
+86,093
+20% +$4.16M
CLF icon
1066
PUT
Cleveland-Cliffs
CLF
$6.45B
$27.2M 0.01%
2,551,100
+334,700
+15% +$3.3M
PDD icon
1067
PUT
Pinduoduo
PDD
$124B
$27.2M 0.01%
1,318,400
+671,500
+104% +$14.5M
BHP icon
1068
CALL
BHP
BHP
$247B
$27.2M 0.01%
524,180
-272,291
-34% -$13.2M
TT icon
1069
CALL
Trane Technologies
TT
$99.7B
$27.1M 0.01%
214,300
-2,400
-1% -$287K
MTD icon
1070
PUT
Mettler-Toledo International
MTD
$28B
$27.1M 0.01%
32,300
+6,100
+23% +$4.6M
MCHP icon
1071
CALL
Microchip Technology
MCHP
$40.3B
$27.1M 0.01%
624,800
-190,000
-23% -$8.44M
ARRY
1072
DELISTED
Array Biopharma Inc
ARRY
$26.9M 0.01%
+581,140
New +$16.3M
IQ icon
1073
iQIYI
IQ
$975M
$26.9M 0.01%
1,302,672
+875,923
+205% +$18.1M
BMRN icon
1074
CALL
BioMarin Pharmaceuticals
BMRN
$12.6B
$26.9M 0.01%
314,000
+12,600
+4% +$1.08M
VMC icon
1075
CALL
Vulcan Materials
VMC
$35.8B
$26.9M 0.01%
195,800
-168,200
-46% -$21.5M

Similar funds

Jeff Yass's Q2 2019 Portfolio in Review

As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $25.4B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.

  • Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
  • Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
  • Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
  • Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
  • Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
  • Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
  • Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.